Alimoglu Orhan, Ozkan Orhan V, Sahin Mustafa, Akcakaya Adem, Eryilmaz Ramazan, Bas Gurhan
First Department of Surgery, Vakif Gureba Training Hospital, 34280 Capa, Istanbul, Turkey.
World J Surg. 2003 Mar;27(3):256-9. doi: 10.1007/s00268-002-6647-3. Epub 2003 Feb 27.
Biliary stones are the leading cause of acute pancreatitis. Although cholecystectomy and selective endoscopic retrograde cholangiography (ERC) comprise the current treatment in patients with acute biliary pancreatitis (ABP), the time of intervention is still controversial. In this study we evaluated the outcomes of cholecystectomy on first admission for ABP and in patients with recurrent biliary pancreatitis. A series of 43 patients with ABP between January 1997 and November 2000 were evaluated retrospectively. Patients were classified into two groups. Group I included 27 patients who underwent cholecystectomy on first admission before discharge from the hospital. Group II comprised 16 patients who had recurrent biliary pancreatitis and then underwent cholecystectomy. The severity of the pancreatitis was determined by Ranson's criteria. Age, gender, length of hospital stay, severity of pancreatitis, amylase level, and complications of cholecystectomy were evaluated in both groups. Patients in group I underwent cholecystectomy during the original hospital admission and patients in group II during an admission for a recurrence. There were 24 patients with a Ranson's score </= 3 in group I and 12 in group II. The mean hospital stays were 15.29 days (range 4-48 days) and 36.66 days (range 15-123 days) in groups I and II, respectively ( p = 0.006). Morbidity was 11% without mortality in group I and 43% with one mortality in group II ( p = 0.023). Definitive treatment of ABP can be accomplished effectively and safely by cholecystectomy following clinical improvement, with selective ERC performed during the first admission (delayed cholecystectomy). Waiting to perform cholecystectomy (interval cholecystectomy) may result in recurrent biliary pancreatitis, which may increase morbidity and the length of the hospital stay.
胆石症是急性胰腺炎的主要病因。虽然胆囊切除术和选择性内镜逆行胆管造影术(ERC)是目前治疗急性胆源性胰腺炎(ABP)患者的方法,但干预时机仍存在争议。在本研究中,我们评估了ABP首次入院时行胆囊切除术以及复发性胆源性胰腺炎患者行胆囊切除术的结果。回顾性评估了1997年1月至2000年11月期间的43例ABP患者。患者分为两组。第一组包括27例在首次入院出院前接受胆囊切除术的患者。第二组包括16例复发性胆源性胰腺炎患者,随后接受了胆囊切除术。胰腺炎的严重程度由兰森标准确定。对两组患者的年龄、性别、住院时间、胰腺炎严重程度、淀粉酶水平和胆囊切除术后并发症进行了评估。第一组患者在原住院期间接受胆囊切除术,第二组患者在复发住院期间接受胆囊切除术。第一组有24例兰森评分≤3分的患者,第二组有12例。第一组和第二组的平均住院时间分别为15.29天(范围4 - 48天)和36.66天(范围15 - 123天)(p = 0.006)。第一组的发病率为11%,无死亡病例;第二组的发病率为43%,有1例死亡(p = 0.023)。临床症状改善后通过胆囊切除术可有效且安全地完成ABP的确定性治疗,并在首次入院时进行选择性ERC(延迟胆囊切除术)。等待进行胆囊切除术(间隔胆囊切除术)可能会导致复发性胆源性胰腺炎,这可能会增加发病率和住院时间。